FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Federica Barbieri

Research Profile

Anatomy

Physiology

Chemicals & Drugs

Disorders

Procedures

Concepts & Ideas

Drug Dose Response Relationship

Co-author Network

Publications

TOP 3
Elisa Carra; Federica Barbieri; Roberto Favoni; Tullio Florio; Daniela Marubbi; Alessandra Pattarozzi; Antonio Daga
Sorafenib selectively depletes human glioblastoma tumor-initiating cells from primary cultures.
Federica Barbieri; Alessandro Corsaro; Adriana Bajetto; Monica Gatti; Mario Nizzari; Alessandra Pattarozzi; Stefano Thellung; Valentina Villa; Roberto Würth; Tullio Florio
Peptide receptor targeting in cancer: the somatostatin paradigm.
Roberto Würth; Gianluigi Zona; Adriana Bajetto; Federica Barbieri; Alessandro Corsaro; Antonio Daga; Daniela Fenoglio; Gilberto Filaci; Monica Gatti; Cecilia Marini; Michela Massollo; Alessia Parodi; Alessandra Pattarozzi; Gianmario Sambuceti; Rodolfo Sirito; Tullio Florio
Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of Akt.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Federica Barbieri (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Elisa Carra; Federica Barbieri; Roberto Favoni; Tullio Florio; Daniela Marubbi; Alessandra Pattarozzi; Antonio Daga
Sorafenib selectively depletes human glioblastoma tumor-initiating cells from primary cultures.
Cell cycle (Georgetown, Tex.) 2013;12(3):491-500.
2013: Federica Barbieri; Alessandro Corsaro; Adriana Bajetto; Monica Gatti; Mario Nizzari; Alessandra Pattarozzi; Stefano Thellung; Valentina Villa; Roberto Würth; Tullio Florio
Peptide receptor targeting in cancer: the somatostatin paradigm.
International journal of peptides 2013;2013():926295.
2013: Roberto Würth; Gianluigi Zona; Adriana Bajetto; Federica Barbieri; Alessandro Corsaro; Antonio Daga; Daniela Fenoglio; Gilberto Filaci; Monica Gatti; Cecilia Marini; Michela Massollo; Alessia Parodi; Alessandra Pattarozzi; Gianmario Sambuceti; Rodolfo Sirito; Tullio Florio
Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of Akt.
Cell cycle (Georgetown, Tex.) 2013;12(1):145-56.
2012: Tullio Florio; Federica Barbieri
The status of the art of human malignant glioma management: the promising role of targeting tumor-initiating cells.
Drug discovery today 2012;17(19-20):1103-10.
2012: Federica Barbieri; Chiara Campanella; Michele Cilli; Antonio Daga; Angelo Ferrari; Alessandra Ratto; Stefano Thellung; Guendalina Vito; Roberto Wurth; Tullio Florio
Isolation of stem-like cells from spontaneous feline mammary carcinomas: phenotypic characterization and tumorigenic potential.
Experimental cell research 2012;318(7):847-60.
2012: Federico Gatto; Massimo Giusti; Leo J Hofland; Francesco Minuto; Jean Louis Ravetti; Alexandru Saveanu; Stefan Schulz; Roberto Wurth; Gianluigi Zona; Federica Barbieri; Michael D Culler; Diego Ferone; Monica Gatti; Tullio Florio
Balance between somatostatin and D2 receptor expression drives TSH-secreting adenoma response to somatostatin analogues and dopastatins.
Clinical endocrinology 2012;76(3):407-14.
2012: Angelo Ferrari; Federica Barbieri; Chiara Campanella; Claudio Petterino; Alessandra Ratto; Stefano Thellung; Guendalina Vito; Roberto Wurth; Tullio Florio
CXCR4 expression in feline mammary carcinoma cells: evidence of a proliferative role for the SDF-1/CXCR4 axis.
BMC veterinary research 2012;8():27.
2012: Mario Nizzari; Aldo Pagano; Daniela Passarella; Federica Barbieri; Calentina Caorsi; Luca Colucci-D'Amato; Alberto Diaspro; Tullio Florio; Maria Teresa Gentile; Maurizio Taglialatela; Claudio Russo
Amyloid-β protein precursor regulates phosphorylation and cellular compartmentalization of microtubule associated protein tau.
Journal of Alzheimer's disease : JAD 2012;29(1):211-27.
2011: Federica Barbieri; Roberto Favoni; Angelo Ferrari; Monica Gatti; Alessandra Pattarozzi; Alessandra Ratto; Roberto Würth; Adriana Bajetto; Tullio Florio
Receptor tyrosine kinase inhibitors and cytotoxic drugs affect pleural mesothelioma cell proliferation: insight into EGFR and ERK1/2 as antitumor targets.
Biochemical pharmacology 2011;82(10):1467-77.
2011: Paolo Giannoni; Roberto Narcisi; Manuela Parodi; Alessandra Pattarozzi; Rodolfo Quarto; Silvia Scaglione; Enrico Balleari; Federica Barbieri; Giorgio Corte; Silvano Ferrini; Tullio Florio; Daniela de Totero
An interaction between hepatocyte growth factor and its receptor (c-MET) prolongs the survival of chronic lymphocytic leukemic cells through STAT3 phosphorylation: a potential role of mesenchymal cells in the disease.
Haematologica 2011;96(7):1015-23.
2011: Federico Gatto; Federica Barbieri; Lara Castelletti; Marica Arvigo; Alessandra Pattarozzi; Francesca Annunziata; Alexandru Saveanu; Francesco Minuto; Lucio Castellan; Gianluigi Zona; Tullio Florio; Diego Ferone
In vivo and in vitro response to octreotide LAR in a TSH-secreting adenoma: characterization of somatostatin receptor expression and role of subtype 5.
Pituitary 2011;14(2):141-7.
2011: Roberto Würth; Federica Barbieri; Adriana Bajetto; Alessandra Pattarozzi; Monica Gatti; Carola Porcile; Gianluigi Zona; Jean Louis Ravetti; Renato Spaziante; Tullio Florio
Expression of CXCR7 chemokine receptor in human meningioma cells and in intratumoral microvasculature.
Journal of neuroimmunology 2011;234(1-2):115-23.
2011: Sara Massone; Irene Vassallo; Gloria Fiorino; Manuele Castelnuovo; Federica Barbieri; Roberta Borghi; Massimo Tabaton; Mauro Robello; Elena Gatta; Claudio Russo; Tullio Florio; Giorgio Dieci; Ranieri Cancedda; Aldo Pagano
17A, a novel non-coding RNA, regulates GABA B alternative splicing and signaling in response to inflammatory stimuli and in Alzheimer disease.
Neurobiology of disease 2011;41(2):308-17.
2010: Roberto E Favoni; Alessandra Pattarozzi; Michele Lo Casto; Federica Barbieri; Monica Gatti; Laura Paleari; Adriana Bajetto; Carola Porcile; Giovanni Gaudino; Luciano Mutti; Giorgio Corte; Tullio Florio
Gefitinib targets EGFR dimerization and ERK1/2 phosphorylation to inhibit pleural mesothelioma cell proliferation.
Current cancer drug targets 2010;10(2):176-91.
2010: Federica Barbieri; Adriana Bajetto; Tullio Florio
Role of chemokine network in the development and progression of ovarian cancer: a potential novel pharmacological target.
Journal of oncology 2010;2010():426956.
2009: Federica Barbieri; Michael D Culler; Angelo Ferrari; Monica Gatti; Gianluigi Lunardi; Alessandra Pattarozzi; Ana Quintero; Cinzia Aiello; Adriana Bajetto; Tullio Florio
Differential efficacy of SSTR1, -2, and -5 agonists in the inhibition of C6 glioma growth in nude mice.
American journal of physiology. Endocrinology and metabolism 2009;297(5):E1078-88.
2009: Fabrizio Griffero; Antonio Daga; Daniela Marubbi; Maria Cristina Capra; Alice Melotti; Alessandra Pattarozzi; Monica Gatti; Adriana Bajetto; Carola Porcile; Federica Barbieri; Roberto E Favoni; Michele Lo Casto; Gianluigi Zona; Renato Spaziante; Tullio Florio; Giorgio Corte
Different response of human glioma tumor-initiating cells to epidermal growth factor receptor kinase inhibitors.
The Journal of biological chemistry 2009;284(11):7138-48.
2008: Federica Barbieri; Alessandra Pattarozzi; Monica Gatti; Carola Porcile; Adriana Bajetto; Angelo Ferrari; Michael D Culler; Tullio Florio
Somatostatin receptors 1, 2, and 5 cooperate in the somatostatin inhibition of C6 glioma cell proliferation in vitro via a phosphotyrosine phosphatase-eta-dependent inhibition of extracellularly regulated kinase-1/2.
Endocrinology 2008;149(9):4736-46.
2008: Federica Barbieri; Adriana Bajetto; Ralf Stumm; Alessandra Pattarozzi; Carola Porcile; Gianluigi Zona; Alessandra Dorcaratto; Jean Louis Ravetti; Francesco Minuto; Renato Spaziante; Gennaro Schettini; Diego Ferone; Tullio Florio
Overexpression of stromal cell-derived factor 1 and its receptor CXCR4 induces autocrine/paracrine cell proliferation in human pituitary adenomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(16):5022-32.
2008: Tullio Florio; Federica Barbieri; Renato Spaziante; Gianluigi Zona; Leo J Hofland; Peter M Van Koetsveld; Richard A Feelders; Günter K Stalla; Marily Theodoropoulou; Michael D Culler; Jesse Dong; John E Taylor; Jacques-Pierre Moreau; Alexandru Saveanu; Ginette Gunz; Henry Dufour; Philippe Jaquet
Efficacy of a dopamine-somatostatin chimeric molecule, BIM-23A760, in the control of cell growth from primary cultures of human non-functioning pituitary adenomas: a multi-center study.
Endocrine-related cancer 2008;15(2):583-96.
2008: Alessandra Pattarozzi; Monica Gatti; Federica Barbieri; Roberto Würth; Carola Porcile; Gianluigi Lunardi; Alessandra Ratto; Roberto Favoni; Adriana Bajetto; Angelo Ferrari; Tullio Florio
17beta-estradiol promotes breast cancer cell proliferation-inducing stromal cell-derived factor-1-mediated epidermal growth factor receptor transactivation: reversal by gefitinib pretreatment.
Molecular pharmacology 2008;73(1):191-202.
2007: Angela Alama; Federica Barbieri; Renato Spaziante; Cristina Bruzzo; Patrizia Dadati; Alessandra Dorcaratto; Jean Louis Ravetti
Significance of cyclin D1 expression in meningiomas: a preliminary study.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2007;14(4):355-8.
2007: Federica Barbieri; Adriana Bajetto; Carola Porcile; Alessandra Pattarozzi; Gennaro Schettini; Tullio Florio
Role of stromal cell-derived factor 1 (SDF1/CXCL12) in regulating anterior pituitary function.
Journal of molecular endocrinology 2007;38(3):383-9.
2007: Giovannella Palmieri; Liliana Montella; Cinzia Aiello; Federica Barbieri; Dolores Di Vizio; S Schulz; Simone Beninati; Alfredo Budillon; Michele Caraglia; Luigi Insabato; Tullio Florio
Somatostatin analogues, a series of tissue transglutaminase inducers, as a new tool for therapy of mesenchimal tumors of the gastrointestinal tract.
Amino acids 2007;32(3):395-400.
2007: Adriana Bajetto; Federica Barbieri; Alessandra Pattarozzi; Alessandra Dorcaratto; Carola Porcile; Jean Louis Ravetti; Gianluigi Zona; Renato Spaziante; Gennaro Schettini; Tullio Florio
CXCR4 and SDF1 expression in human meningiomas: a proliferative role in tumoral meningothelial cells in vitro.
Neuro-oncology 2007;9(1):3-11.
2006: Alessandro Massa; Silvia Casagrande; Adriana Bajetto; Carola Porcile; Federica Barbieri; Stefano Thellung; Sara Arena; Alessandra Pattarozzi; Monica Gatti; Alessandro Corsaro; Mauro Robello; Gennaro Schettini; Tullio Florio
SDF-1 controls pituitary cell proliferation through the activation of ERK1/2 and the Ca2+-dependent, cytosolic tyrosine kinase Pyk2.
Annals of the New York Academy of Sciences 2006;1090():385-98.
2006: Federica Barbieri; Adriana Bajetto; Carola Porcile; Alessandra Pattarozzi; Alessandro Massa; Gianluigi Lunardi; Gianluigi Zona; Alessandra Dorcaratto; Jean Louis Ravetti; Renato Spaziante; Gennaro Schettini; Tullio Florio
CXC receptor and chemokine expression in human meningioma: SDF1/CXCR4 signaling activates ERK1/2 and stimulates meningioma cell proliferation.
Annals of the New York Academy of Sciences 2006;1090():332-43.
2006: Adriana Bajetto; Federica Barbieri; Alessandra Dorcaratto; Simone Barbero; Antonio Daga; Carola Porcile; Jean Louis Ravetti; Gianluigi Zona; Renato Spaziante; Giorgio Corte; Gennaro Schettini; Tullio Florio
Expression of CXC chemokine receptors 1-5 and their ligands in human glioma tissues: role of CXCR4 and SDF1 in glioma cell proliferation and migration.
Neurochemistry international 2006;49(5):423-32.
2005: Carola Porcile; Adriana Bajetto; Federica Barbieri; Simone Barbero; Rudy Bonavia; Marianna Biglieri; Paolo Pirani; Tullio Florio; Gennaro Schettini
Stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12) stimulates ovarian cancer cell growth through the EGF receptor transactivation.
Experimental cell research 2005;308(2):241-53.
2004: Alessandro Massa; Federica Barbieri; Cinzia Aiello; Rodolfo Iuliano; Sara Arena; Alessandra Pattarozzi; Alessandro Corsaro; Valentina Villa; Alfredo Fusco; Gianluigi Zona; Renato Spaziante; Gennaro Schettini; Tullio Florio
The phosphotyrosine phosphatase eta mediates somatostatin inhibition of glioma proliferation via the dephosphorylation of ERK1/2.
Annals of the New York Academy of Sciences 2004;1030():264-74.
2004: Alessandro Massa; Federica Barbieri; Cinzia Aiello; Sara Arena; Alessandra Pattarozzi; Paolo Pirani; Alessandro Corsaro; Rodolfo Iuliano; Alfredo Fusco; Gianluigi Zona; Renato Spaziante; Tullio Florio; Gennaro Schettini
The expression of the phosphotyrosine phosphatase DEP-1/PTPeta dictates the responsivity of glioma cells to somatostatin inhibition of cell proliferation.
The Journal of biological chemistry 2004;279(28):29004-12.
2004: Marino Novi; Massimo Ottone; Carlo Dell'Erba; Federica Barbieri; Barbara Chiavarina; Massimo Maccagno; Maurizio Viale
1,4-Bis(1-naphthyl)-2,3-dinitro-1,3-butadiene a novel anticancer compound effective against tumor cell lines characterized by different mechanisms of resistance.
Oncology reports 2004;12(1):91-6.
2004: Federica Barbieri; Paola Lorenzi; Nicola Ragni; Gennaro Schettini; Cristina Bruzzo; Francesco Pedullà; Angela Alama
Overexpression of cyclin D1 is associated with poor survival in epithelial ovarian cancer.
Oncology 2004;66(4):310-5.
2004: Sara Arena; Federica Barbieri; Stefano Thellung; Paolo Pirani; Alessandro Corsaro; Valentina Villa; Patrizia Dadati; Alessandra Dorcaratto; Gabriella Lapertosa; Jean Louis Ravetti; Renato Spaziante; Gennaro Schettini; Tullio Florio
Expression of somatostatin receptor mRNA in human meningiomas and their implication in in vitro antiproliferative activity.
Journal of neuro-oncology 2004;66(1-2):155-66.
2003: Federica Barbieri; Angela Alama; Bruno Tasso; Vito Boido; Cristina Bruzzo; Fabio Sparatore
Quinolizidinyl derivatives of iminodibenzyl and phenothiazine as multidrug resistance modulators in ovarian cancer cells.
Investigational new drugs 2003;21(4):413-20.
2003: Tullio Florio; Stefano Thellung; Alessandro Corsaro; Liliana Bocca; Sara Arena; Alessandra Pattarozzi; Valentina Villa; Alessandro Massa; Fabrizio Diana; Daria Schettini; Federica Barbieri; Jean Louis Ravetti; Renato Spaziante; Massimo Giusti; Gennaro Schettini
Characterization of the intracellular mechanisms mediating somatostatin and lanreotide inhibition of DNA synthesis and growth hormone release from dispersed human GH-secreting pituitary adenoma cells in vitro.
Clinical endocrinology 2003;59(1):115-28.
2003: Federica Barbieri; Anna Sparatore; Angela Alama; Federica Novelli; Cristina Bruzzo; Fabio Sparatore
Novel sigma binding site ligands as inhibitors of cell proliferation in breast cancer.
Oncology research 2003;13(11):455-61.
2002: Federica Barbieri; Fabio Sparatore; Rudy Bonavia; Cristina Bruzzo; Gennaro Schettini; Angela Alama
Chemosensitivity of glioblastoma cells during treatment with the organo-tin compound triethyltin(IV)lupinylsulfide hydrochloride.
Journal of neuro-oncology 2002;60(2):109-16.
2002: Federica Barbieri; Maurizio Viale; Fabio Sparatore; Gennaro Schettini; Anna Favre; Cristina Bruzzo; Federica Novelli; Angela Alama
Antitumor activity of a new orally active organotin compound: a preliminary study in murine tumor models.
Anti-cancer drugs 2002;13(6):599-604.
2001: Mauro Mazzei; Monica Miele; Erika Nieddu; Federica Barbieri; Cristina Bruzzo; Angela Alama
Unsymmetrical methylene derivatives of indoles as antiproliferative agents.
European journal of medicinal chemistry 2001;36(11-12):915-23.
2001: Federica Barbieri; Fabio Sparatore; M Cagnoli; Cristina Bruzzo; Federica Novelli; Angela Alama
Antiproliferative activity and interactions with cell-cycle related proteins of the organotin compound triethyltin(IV)lupinylsulfide hydrochloride.
Chemico-biological interactions 2001;134(1):27-39.
2000: Federica Barbieri; Maurizio Viale; Fabio Sparatore; A Favre; M Cagnoli; Cristina Bruzzo; Federica Novelli; Angela Alama
Cytotoxicity in vitro and preliminary antitumor activity in vivo of a novel organotin compound.
Anticancer research 2000;20(2A):977-80.
1999: Federica Barbieri; M Cagnoli; Nicola Ragni; Giovanni Foglia; Cristina Bruzzo; Francesco Pedullà; Angela Alama
Increased cyclin D1 expression is associated with features of malignancy and disease recurrence in ovarian tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(7):1837-42.
1998: M Cagnoli; Federica Barbieri; Cristina Bruzzo; Angela Alama
Control of cyclin D1 expression by antisense oligonucleotides in three ovarian cancer cell lines.
Gynecologic oncology 1998;70(3):372-7.
1998: M Cagnoli; Angela Alama; Federica Barbieri; Federica Novelli; Cristina Bruzzo; Fabio Sparatore
Synthesis and biological activity of gold and tin compounds in ovarian cancer cells.
Anti-cancer drugs 1998;9(7):603-10.
1997: Angela Alama; Federica Barbieri; M Cagnoli; Gennaro Schettini
Antisense oligonucleotides as therapeutic agents.
Pharmacological research : the official journal of the Italian Pharmacological Society 1997;36(3):171-8.
1997: Federica Barbieri; M Cagnoli; Nicola Ragni; Francesco Pedullà; Giovanni Foglia; Angela Alama
Expression of cyclin D1 correlates with malignancy in human ovarian tumours.
British journal of cancer 1997;75(9):1263-8.
1996: Angela Alama; Federica Barbieri; A Favre; M Cagnoli; E Noviello; F Pedullà; M Viale; Giovanni Foglia; Nicola Ragni
Establishment and characterization of three new cell lines derived from the ascites of human ovarian carcinomas.
Gynecologic oncology 1996;62(1):82-8.
1996: Angela Alama; Federica Barbieri; M Cagnoli; Mauro Mazzei; T Grandi; Annamaria Bevilacqua
Inhibition of DNA polymerase alpha expression and cell growth, a possible triple helix mechanism.
Antisense & nucleic acid drug development 1996;6(2):95-101.
1994: Federica Barbieri; G Parodi; T Massa; M Cagnoli; G Barbi; Alessio Imperiale; Angela Alama
Feasibility of thymidine labelling index on fine needle aspirates from breast cancer: comparison with surgical samples.
Anticancer research 1994;14(5A):1973-7.